Auxly Financial Statements From 2010 to 2025
| XLY Stock | CAD 0.09 0.01 5.26% |
Check Auxly Cannabis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Auxly Cannabis' main balance sheet or income statement drivers, such as , as well as many indicators such as . Auxly financial statements analysis is a perfect complement when working with Auxly Cannabis Valuation or Volatility modules.
Auxly |
Auxly Cannabis Group Company Shares Outstanding Analysis
Auxly Cannabis' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Auxly Cannabis Shares Outstanding | 1.31 B |
Most of Auxly Cannabis' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Auxly Cannabis Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Auxly Cannabis Group has 1.31 B of shares currently outstending. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares outstanding for all Canada stocks is 129.96% lower than that of the firm.
Auxly Cannabis Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Auxly Cannabis's current stock value. Our valuation model uses many indicators to compare Auxly Cannabis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Auxly Cannabis competition to find correlations between indicators driving Auxly Cannabis's intrinsic value. More Info.Auxly Cannabis Group is rated second in return on equity category among its peers. It is rated first in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Auxly Cannabis by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Auxly Cannabis' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Auxly Cannabis Financial Statements
Auxly Cannabis investors utilize fundamental indicators, such as revenue or net income, to predict how Auxly Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Toronto, Canada. AUXLY CANNABIS operates under Drug ManufacturersSpecialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs 558 people.
Other Information on Investing in Auxly Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.